전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-1 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,403 programs
AntibodyLimited DatastaleUniversity Hospital Fattouma Bo…Approved

Preoperative Intra-lesional Bevacizumab Injection in primary pterygium (Preoperative Intra-lesional Bevacizumab Injection in primary pterygium)

Pterygium · Pterygium

#Pterygium#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Active
CGTLimited DatastaleNovartis PharmaceuticalsPhase 3

Previously treated CAR-T patients (Previously treated CAR-T patients)

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program · Long Term Safety of Patients Receiving C

#LongTermSafetyofPatientsReceivin#CGT#Phase3#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleMustang BioPreclinical

Prior MB-102 CAR-T cell investigational product. (Prior MB-102 CAR-T cell investigational product.)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Chronic Lymphocytic Leukemia in Relapse · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleMustang BioPreclinical

Prior MB-106 CAR-T cell investigational product. (Prior MB-106 CAR-T cell investigational product.)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Chronic Lymphocytic Leukemia in Relapse · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTAAVLimited DatastaleMeiraGTx UK II LtdPreclinical

Prior exposure to AAV-CNGA3 or AAV-CNGB3 (Prior exposure to AAV-CNGA3 or AAV-CNGB3)

Achromatopsia · Achromatopsia

#Achromatopsia#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTLimited DatastaleBeijing GoBroad HospitalPhase 2

Prior-HSCT donor-derived CD7 CAR T-cell (Prior-HSCT donor-derived CD7 CAR T-cell)

T-cell Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital, GhentApproved

Proactive TDM-based dosing of guselkumab (Proactive TDM-based dosing of guselkumab)

Psoriasis Vulgaris · Psoriasis Vulgaris

#PsoriasisVulgaris#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital, GhentApproved

Proactive TDM-based dosing of ixekizumab (Proactive TDM-based dosing of ixekizumab)

Psoriasis Vulgaris · Psoriasis Vulgaris

#PsoriasisVulgaris#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversity Hospital, GhentApproved

Proactive TDM-based dosing of secukinumab (Proactive TDM-based dosing of secukinumab)

Psoriasis Vulgaris · Psoriasis Vulgaris

#PsoriasisVulgaris#Antibody#Approved#monoclonal-antibody#University
Trials 1Status Recruiting
CGTLimited DatastaleTianjin Medical University Seco…Preclinical

Programmed death receptor-1 inhibitor (Programmed death receptor-1 inhibitor)

Malignant Pleural Mesothelioma, Advanced · Malignant Pleural Mesothelioma, Advanced

#MalignantPleuralMesotheliomaAdva#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Active
AntibodyLimited DatastaleHenan Cancer HospitalPreclinical

trastuzumab (Herceptin, Pyrotinib and Trastuzumab plus Vinorelbine)

HER2 Positive Breast Cancer · HER2

#HER2#Antibody#Preclinical#monoclonal-antibody#HER2PositiveBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleFujian Medical University Union…Phase 2

trastuzumab (Herceptin, Pyrotinib+Trastuzumab+Capecitabine)

Breast Cancer; Adjuvant Therapy · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#AdjuvantTherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastaleTianjin Medical University Canc…Phase 2

trastuzumab (Herceptin, Pyrrolidine、trastuzumab、AI)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#monoclonal-antibody#Tianjin
Trials 1Status Active
AntibodyLimited DatastaleThe First Affiliated Hospital w…Phase 2

Iparomlimab/Tuvonralimab (QL1706, QL1706 (Iparomlimab/Tuvonralimab))

Gastric Cancer Stage III · Gastric Cancer Stage III

#GastricCancerStageIII#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPhase 2

daratumumab (Darzalex, QL2109 or Daratumumab)

Relapsed or Refractory Multiple Myeloma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#RelapsedorRefractoryMultipleMyel+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

QLS5132; Bevacizumab (QLS5132; Bevacizumab)

Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

QLS5132; Platinum; Bevacizumab (QLS5132; Platinum; Bevacizumab)

Gastric Cancer (GC); Non-small Cell Lung Cancer (NSCLC) · Gastric Cancer (GC)

#GastricCancerGC#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerNSCLC+1
Trials 1Status Recruiting
AntibodyLimited DatastaleGerman High-Grade Non-Hodgkin's…Phase 3

R-CHOEP 14 with 12x Rituximab (R-CHOEP 14 with 12x Rituximab)

Non-Hodgkin's Lymphoma (NHL) · Non-Hodgkin's Lymphoma (NHL)

#Non-HodgkinsLymphomaNHL#Antibody#Phase3#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleEli LillyPhase 1

RAD001, Cetuximab, Irinotecan (RAD001, Cetuximab, Irinotecan)

Colorectal Cancer; Colorectal Carcinoma · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#monoclonal-antibody#ColorectalCarcinoma+1
Trials 1Status Active
ADCLimited DatastaleSecond Affiliated Hospital, Zhe…Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC plus Bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#ADC#Phase2#antibody-drug-conjugate#Second
Trials 1Status Active

97 / 121 pages

← PreviousNext →